{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:06:02Z","timestamp":1779912362949,"version":"3.53.1"},"reference-count":34,"publisher":"Biomedical Research Press","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed. Res."],"published-print":{"date-parts":[[2022,10,14]]},"DOI":"10.2220\/biomedres.43.173","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T22:22:36Z","timestamp":1665699756000},"page":"173-180","source":"Crossref","is-referenced-by-count":2,"title":["Activation of STAT3 (signal transducer and activator of transcription 3) in synovial tissues from the hip joint in the early stage of rapidly destructive coxopathy"],"prefix":"10.2220","volume":"43","author":[{"given":"Tadashi","family":"YASUDA","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"HARA","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinnosuke","family":"YAMASHITA","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaki","family":"MITSUZAWA","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"TSUKAMOTO","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisataka","family":"TAKEUCHI","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"OTA","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eijiro","family":"ONISHI","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1059","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abe H, Sakai T, Ando W, Takao M, Nishii T, <i>et al.<\/i> (2014) Synovial joint fluid cytokine levels in hip disease. <i>Rheumatology (Oxford) <\/i><b>53<\/b>, 165\u2013172.","DOI":"10.1093\/rheumatology\/ket334"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Araki Y, Tsuzuki-Wada T, Aizaki Y, Sato K, Yokota K, <i>et al.<\/i> (2016) Histone methylation and STAT-3 differentially regulate interleukin-6\u2013induced matrix metalloproteinase gene activation in rheumatoid arthritis synovial fibroblasts. <i>Arthritis Rheumatol <\/i><b>68<\/b>, 1111\u20131123.","DOI":"10.1002\/art.39563"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Asif Amin M, Fox DA and Ruth JH (2017) Synovial cellular and molecular markers in rheumatoid arthritis. <i>Semin Immunopathol <\/i><b>39<\/b>, 385\u2013393.","DOI":"10.1007\/s00281-017-0631-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Boyle DL, Soma K, Hodge J, Kavanaugh A, Mandel D, <i>et al.<\/i> (2015) The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis. <i>Ann Rheum <\/i><i>Dis <\/i><b>74<\/b>, 1311\u20131316.","DOI":"10.1136\/annrheumdis-2014-206028"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Burmester GR, Blanco R, Charles-Schoeman C, Wollenhaupt J, Zerbini C, <i>et al.<\/i> (2013) Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial. <i>Lancet <\/i><b>381<\/b>, 451\u2013460.","DOI":"10.1016\/S0140-6736(12)61424-X"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Burrage PS, Mix KS and Brinckerhoff CE (2006) Matrix metalloproteinases: role in arthritis. <i>Front Biosci <\/i><b>11<\/b>, 529\u2013543.","DOI":"10.2741\/1817"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Charrois O, Kahwaji A, Vastel L, Rosencher N and Courpied JP (2001) Blood loss in total hip arthroplasty for rapidly destructive coxarthrosis. <i>Int Orthop <\/i><b>25<\/b>, 22\u201324.","DOI":"10.1007\/s002640000210"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Conaghan PG, \u00d8stergaard M, Bowes MA, Wu C, Fuerst T, <i>et al.<\/i> (2016) Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques. <i>Ann Rheum Dis <\/i><b>75<\/b>, 1024\u20131033.","DOI":"10.1136\/annrheumdis-2015-208267"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Culemann S, Gr\u00fcneboom A, Nicol\u00e1s-\u00c1vila J\u00c1, Weidner D, L\u00e4mmle KF, <i>et al.<\/i> (2019) Locally renewing resident synovial macrophages provide a protective barrier for the joint. <i>Nature <\/i><b>572<\/b>, 670\u2013675.","DOI":"10.1038\/s41586-019-1471-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Emori T, Kasahara M, Sugahara S, Hashimoto M, Ito H, <i>et al.<\/i> (2000) Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib. <i>Eur J Pharmacol <\/i><b>882<\/b>, 173238.","DOI":"10.1016\/j.ejphar.2020.173238"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Fleischmann R, Kremer J, Cush J, Schulze-Koops H, Connell CA, <i>et al.<\/i> (2012) Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis. <i>N Engl J Med <\/i><b>367<\/b>, 495\u2013507.","DOI":"10.1056\/NEJMoa1109071"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Garbers C, Aparicio-Siegmund S and Rose-John S (2015) The IL-6\/gp130\/STAT3 signaling axis: recent advances towards specific inhibition. <i>Curr Opin Immunol <\/i><b>34<\/b>, 75\u201382.","DOI":"10.1016\/j.coi.2015.02.008"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Komiya S, Inoue A, Sasaguri Y, Minamitani K and Morimatsu M (1992) Rapidly destructive arthropathy of the hip. Studies on bone resorptive factors in joint fluid with a theory of pathogenesis. <i>Clin Orthop Relat Res <\/i><b>284<\/b>, 273\u2013282.","DOI":"10.1097\/00003086-199211000-00038"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Kremer J, Li ZG, Hall S, Fleischmann R, Genovese M, <i>et al.<\/i> (2013) Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial. <i>Ann Intern Med <\/i><b>159<\/b>, 253-261.","DOI":"10.7326\/0003-4819-159-4-201308200-00006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Lee EB, Fleischmann R, Hall S, Wilkinson B, Bradley JD, <i>et al.<\/i> (2014) Tofacitinib versus methotrexate in rheumatoid arthritis. <i>N Engl J Med <\/i><b>370<\/b>, 2377\u20132386.","DOI":"10.1056\/NEJMoa1310476"},{"key":"16","unstructured":"Lequesne M (1970) Rapid destructive coxarthritis. <i>Rhumatologie <\/i><b>2<\/b>, 51\u201363 (In French)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Masuhara K, Bak Lee S, Nakai T, Sugano N, Ochi T, <i>et al.<\/i> (2000) Matrix metalloproteinases in patients with osteoarthritis of the hip. <i>Int Orthop <\/i><b>24<\/b>, 92\u201396.","DOI":"10.1007\/s002640000110"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Masuhara K, Nakai T, Yamaguchi K, Yamasaki S and Sasaguri Y (2002) Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip. <i>Arthritis Rheum <\/i><b>46<\/b>, 2625\u20132631.","DOI":"10.1002\/art.10547"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Mauviel A (1993) Cytokine regulation of metalloproteinase gene expression. <i>J Cell Biochem <\/i><b>53<\/b>, 288\u2013295.","DOI":"10.1002\/jcb.240530404"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Meyer DM, Jesson MI, Li X, Elrick MM, Funckes-Shippy CL, <i>et al.<\/i> (2010) Anti-inflammatory activity and neutrophil reductions mediated by the JAK1\/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis. <i>J Inflamm (Lond) <\/i><b>7<\/b>, 41.","DOI":"10.1186\/1476-9255-7-41"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Ogawa K, Mawatari M, Komine M, Shigematsu M, Kitajima M, <i>et al.<\/i> (2007) Mature and activated osteoclasts exist in the synovium of rapidly destructive coxarthrosis. <i>J Bone Miner Metab <\/i><b>25<\/b>, 354\u2013360.","DOI":"10.1007\/s00774-007-0761-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Oike T, Sato Y, Kobayashi T, Miyamoto K, Nakamura S, <i>et al.<\/i> (2017) Stat3 as a potential therapeutic target for rheumatoid arthritis. <i>Sci Rep <\/i><b>7<\/b>, 10965.","DOI":"10.1038\/s41598-017-11233-w"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Okada Y, Nagase H and Harris ED Jr (1986) A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. <i>J Biol Chem <\/i><b>261<\/b>, 14245\u201314255.","DOI":"10.1016\/S0021-9258(18)67011-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Pap T, M\u00fcller-Ladner U, Gay RE and Gay S (2000) Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. <i>Arthritis Res <\/i><b>2<\/b>, 361\u2013367.","DOI":"10.1186\/ar113"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Postel M and Kerboull M (1970) Total prosthetic replacement in rapidly destructive arthrosis of the hip joint. <i>Clin Orthop <\/i><i>Relat Res <\/i><b>72<\/b>, 138\u2013144.","DOI":"10.1097\/00003086-197009000-00016"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Smith MD, Barg E, Weedon H, Papengelis V, Smeets T, <i>et al.<\/i> (2003) Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints. <i>Ann Rheum Dis <\/i><b>62<\/b>, 303\u2013307.","DOI":"10.1136\/ard.62.4.303"},{"key":"27","doi-asserted-by":"crossref","unstructured":"van der Heijde D, Tanaka Y, Fleischmann R, Keystone E, Kremer J, <i>et al.<\/i> (2013) Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study. <i>Arthritis Rheum <\/i><b>65<\/b>, 559\u2013570.","DOI":"10.1002\/art.37816"},{"key":"28","doi-asserted-by":"crossref","unstructured":"van Meurs JB, van Lent PL, Stoop R, Holthuysen A, Singer I, <i>et <\/i><i>al.<\/i> (1999) Cleavage of aggrecan at the ASN<sup>341<\/sup>-PHE<sup>342<\/sup> site coincides with the initiation of collagen damage in murine antigen-induced arthritis. <i>Arthritis Rheum <\/i><b>42<\/b>, 2074\u20132084.","DOI":"10.1002\/1529-0131(199910)42:10<2074::AID-ANR7>3.0.CO;2-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"van Vollenhoven RF, Fleischmann R, Cohen S, Lee EB, Garc\u00eda Meijide JA, <i>et al.<\/i> (2012) Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. <i>N Engl J Med <\/i><b>367<\/b>, 508\u2013519.","DOI":"10.1056\/NEJMoa1112072"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Tamai M, Sagawa K, Kawabata R, Inoue A and Itoh K (1996) Production of IL-6 by T cells from the femoral head of patients with rapidly destructive coxopathy (RDC). <i>Clin Exp <\/i><i>Immunol <\/i><b>103<\/b>, 506\u2013513.","DOI":"10.1111\/j.1365-2249.1996.tb08309.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Wang F, Sengupta TK, Zhong Z and Ivashkiv LB (1995) Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids. <i>J Exp Med <\/i><b>182<\/b>, 1825\u20131831.","DOI":"10.1084\/jem.182.6.1825"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Yasuda T, Matsunaga K, Hashimura T, Tsukamoto Y, Sueyoshi T, <i>et al.<\/i> (2020) Characterization of rapidly progressive osteoarthritis of the hip in its early stage. <i>Eur J Rheumatol <\/i><b>7<\/b>, 130\u2013134.","DOI":"10.5152\/eurjrheum.2020.19159"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Yokota K, Sato K, Miyazaki T, Aizaki Y, Tanaka S, <i>et al.<\/i> (2021) Characterization and function of tumor necrosis factor and interleukin-6\u2013induced osteoclasts in rheumatoid arthritis. <i>Ar<\/i><i>thritis Rheumatol <\/i><b>73<\/b>, 1145\u20131154.","DOI":"10.1002\/art.41666"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Zazgyva A, Gurzu S, Gergely I, Jung I, Roman CO, <i>et al.<\/i> (2017) Clinico-radiological diagnosis and grading of rapidly progressive osteoarthritis of the hip. <i>Medicine (Baltimore) <\/i><b>96<\/b>, e6395.","DOI":"10.1097\/MD.0000000000006395"}],"container-title":["Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/43\/5\/43_173\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T04:52:05Z","timestamp":1665809525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/43\/5\/43_173\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2220\/biomedres.43.173","relation":{},"ISSN":["0388-6107","1880-313X"],"issn-type":[{"value":"0388-6107","type":"print"},{"value":"1880-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]}}}